1. Combination therapy with afatinib and bevacizumab in an EGFR-mutated non-small cell lung cancer patient with acquired ERBB2 amplification
   Sixian Chen et al, 2021, Medicine CrossRef
2. Progress of EGFR-TKI Combined with Bevacizumab in the Treatment of Lung Cancer
   志丹 谢, 2022, Advances in Clinical Medicine CrossRef